Samik Basu

Company: Cabaletta Bio

Job title: Chief Scientific Officer

Seminars:

Industry Leaders Fireside Chat: Evaluating CAR-T in Comparison to Emerging Modalities to Refine Autoimmune Therapies Through Strategic Modality Selection 8:40 am

Explore the efficacy of differing modalities to identify opportunities where we can learn from other modalities Compare modalities in their affinity for targeting autoreactive cells to minimize side-effects and enhance safety Identify autoimmune indications where CD-19-CARs are suboptimal to spotlight opportunities for alternative therapeutic modalitiesRead more

day: Conference Day 1 P1

Keynote Presentation: Showcasing Cabaletta Bio’s Rese-cel Data & Industry Implications to Progress CAR-T in Autoimmunity 9:30 am

Explore rese-cel, a CAR-T cell therapy, combating autoimmune diseases to provide insight into the future of autoimmune cell therapies Discuss how translational and mechanistic insights accelerated the design and development of rese-cel in autoimmunity Evaluate the depth of peripheral and tissue-level target cell depletion with rese-cel in patients with autoimmune diseaseRead more

day: Conference Day 1 P1